In this issue:
Leflunomide plus hydroxychloroquine for Sjögren's disease
Treat-to-target approach and decreasing time to pregnancy for women with RA
Adalimumab versus upadacitinib
Intravenous efgartigimod for Sjögren’s disease
Upadacitinib for IIM-ILD patients
Risk of foot/ankle OA among retired male professional footballers
Efficacy of ixekizumab in r-axSpA
Factors associated with self-reported pain patterns for individuals with gout
Branebrutinib versus placebo for RA
Osteoporosis and hip fractures due to bDMARD exposure
Please login below to download this issue (PDF)